ARCA biopharma Announces C. Jeff Dekker to be Appointed Chief Financial Officer
WESTMINSTER, Colo., May 03, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced C. Jeff Dekker as its Chief Financial Officer, effective May 10, 2021, following Brian Selby’s planned departure after 14 years of service with the Company.
Dr. Michael Bristow, ARCA’s President and Chief Executive Officer commented: “We are delighted to welcome Jeff to ARCA as our Chief Financial Officer. Jeff brings over 25 years of biotech industry and finance experience. I am confident he will be a strong CFO for ARCA. We believe his broad experience and capabilities in all aspects of finance, his fundamental understanding of our business and the industry, and his strong leadership, uniquely enable Jeff to help us continue to drive our clinical development and corporate strategies.”
Dr. Bristow commented further, “Over his 14 years of service, Brian has made invaluable contributions to ARCA. His partnership and guidance directing our financial and accounting organization provided a stable foundation to help advance our clinical development programs. While we will miss his leadership, collaboration and insight, we wish him well in his future endeavors.”
Prior to joining ARCA, Mr. Dekker served in multiple roles of increasing responsibility at GlobeImmune, Inc. from 2006 to 2021, including President, Vice President of Finance, and Senior Director, Finance and Controller. Before joining GlobeImmune, Mr. Dekker held leadership positions in finance and accounting at private software companies since 1993, including posts ranging from Corporate Controller to Vice President at Webroot Software Inc., Requisite Technology Inc. and NxTrend Technology Inc. Earlier in his career, Mr. Dekker worked at ITT Rayonier Port Angeles Pulp Division and at KPMG in Los Angeles. He earneda B.S. in accounting from Utah State University and is a certified public accountant.
About ARCA biopharma
Safe Harbor Statement
Investor & Media Contact:
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/af496e97-20da-420a-bf93-e51b3a3ed740
Key Tools of the IoT Security Trade
CVx #TECHSUPERSHOW Exhibit Hall Open